Formulation and preparation of a nitrendipine submicron emulsion

Asian Journal of Pharmaceutical Sciences

Volumn 6, Issue 3-4, 2011, Pages 151-158

  Zhao, Nana ^a   Qin, Yimeng ^a   Sun, Yinghua ^a   Sun, Jin ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Formulation; Nitrendipine; Preparation; Submicron emulsion

Indexed keywords

LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; NITRENDIPINE; OLEIC ACID; PHOSPHATIDYLCHOLINE; SOYBEAN OIL EMULSION;

ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; MICROEMULSION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; ZETA POTENTIAL;

EID: 80455174087     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davis SS, Washington C, West P, et al. Lipid emulsions as drug delivery systems. Ann N Y Acad Sci. 1987, 507: 75-88.
2. Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technolo Today. 1999, 4: 134-143.
3. Mizushima Yutaka. Lipid microspheres (lipid emulsions) as a drug carrier - an overview. Adv Drug Del Rev. 1996, 20: 113-115.
4. Wang ZY, Sun J, Wang YJ, et al. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010, 383: 1-6.
5. Levy MY, Benita S. Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use. Int J Pharm.1989, 54: 103-112.
6. Férézou J, Nguyen TL, Leray C, et al. Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta. 1994, 1213: 149-58.
7. Groves MJ, Winegerg M, Brain APR. The presence of liposomal material in phosphatide stabilized emulsions. J Disper Sci Technol. 1985, 2: 237-243.
8. Driscoll DF, Bacon MN, Bistrian BR. Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures. J Parenter Enteral Nutr. 2000, 24: 15-22.
9. Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm. 2000, 198: 7-27.
10. Driscoll DF, Giampietro K, Wichelhaus DP, et al. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr. 2001, 20: 151-157.
11. Smyrniotis VE, Kostopanagiotou GG, Arkadopoulos NF, et al. Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange. Clin Nutr. 2001, 20: 139-143.
12. Benita S, Friedman D, Weinstock M. Physostigmine emulsion: a new injectable controlled release delivery system. Int J Pharm. 1986, 30: 47-55.
13. Benita S, Levy MY. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci. 1993, 82: 1069-1079.
14. Eccleston GM. Emulsions. Encyclopedia of Pharmaceutical Technology. Swarbrick J, Boylan JC, (Ed.), 1992, 5: 137-188.
15. Mikrut B. Case study: formulation of an intravenous fat emulsion. injectable dispersed systems: formulation, processing, and performance. Diane J Burgess (Ed.), 2005, 149: 415-425.
16. Davis SS. The stability of fat emulsions for intravenous administration. Current perspectives in the use of lipid emulsion. I.D. Johnston (Ed.), 2nd Int. Sym. Advan Clin Nutr. 1982, 35-61.
17. Yu YL, Lu Y, Tang X, et al. Formulation, preparation and evaluation of an intravenous emulsion containing Brucea javanica oil and Coix Seed oil for anti-tumor application. Biol Pharm Bull. 2008, 31: 673-680.
18. Davis SS, Washington C. Drug emulsion. European Patent 0 296 845 A1.1988 June 22.
19. Bock TK, Lucks JS, Kleinebudde P, et al. High pressure homogenisation of parenteral fat emulsions- influence of process parameters on emulsion quality. Eur J Pharm Biopharm. 1994, 40: 157-160.
20. Shi S, Chen H, Cui Y, et al. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion. Int J Pharm. 2009, 373: 147-155.